Current Appointments & Affiliations
Project Planner I
Duke Clinical & Translational Science Institute,
Institutes and Centers
Recent Publications
Targeting AXL Inhibits the Growth and Metastasis of Prostate Cancer in Bone.
Journal Article Clin Cancer Res · April 1, 2025 PURPOSE: After failing primary and secondary hormonal therapy, castration-resistant and neuroendocrine prostate cancer metastatic to the bone is invariably lethal, although treatment with docetaxel and carboplatin can modestly improve survival. Therefore, ... Full text Link to item CiteSupplementary Table S1 from Targeting AXL Inhibits the Growth and Metastasis of Prostate Cancer in Bone
Other · April 1, 2025 <p>Primary antibodies used for immunohistochemistry (IHC), immunofluorescence (IF), and western blotting (WB)</p> ... Full text CiteSupplementary Figure S4 from Targeting AXL Inhibits the Growth and Metastasis of Prostate Cancer in Bone
Other · April 1, 2025 <p>Figure S4. Quantification of bone mineral density in mouse tibia specimen after treatment for 30 days. Batiraxcept and docetaxel as single agents or in combination increased bone mineral density (BMD) of the tibiae to a similar extent as d ... Full text CiteRecent Grants
Stimulating Access to Research in Residency (StARR) - NHLBI
Inst. Training Prgm or CMEProject Planner · Awarded by National Heart, Lung, and Blood Institute · 2018 - 2028The Paired Undergraduate Mentoring Program (PUMP) in Uronephrology
Inst. Training Prgm or CMEAdministrative Coordinator · Awarded by National Institutes of Health · 2022 - 2027Heat Shock Factor 1 drives prostate cancer progression through production of antioxidants and cellular energy
ResearchPrincipal Investigator · Awarded by Department of Defense · 2021 - 2023View All Grants